Chloramphenicol injection and preparation method thereof
By using a low-level propylene glycol formula in chloramphenicol injection and using centrifugal stirring and ultrasonic homogenization, a microemulsion is formed, which solves the problem of chloramphenicol degradation in aqueous solution, improves its stability and safety, and reduces the The amount of propylene glycol used.
Patent Information
- Application Number
- CN202411010045.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-12-06
AI Technical Summary
The use of propylene glycol in chloramphenicol injection has a safety risk, and chloramphenicol is prone to amide hydrolysis in aqueous solution, resulting in a reduction of effective substances. It is difficult for the prior art to effectively improve its stability and safety.
Using a low-content propylene glycol formula, the injection castor oil is added to the solution of chloramphenicol and propylene glycol for centrifugation and homogenization, forming a microemulsion, and mixing it with additives and water for injection, and ultrasonic homogenization and low-temperature treatment is adopted to treat it. Improve stability and reduce the amount of propylene glycol used.
It significantly improves the stability and safety of chloramphenicol injection, prevents chloramphenicol degradation, reduces the use of propylene glycol, and improves the safety of the product.
Smart Images

Figure BDA0004964055170000071 
Figure BDA0004964055170000072 
Figure BDA0004964055170000082
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of chloramphenicol injection, and in particular to chloramphenicol injection and a preparation method thereof. Background Art
[0002] The main ingredient of chloramphenicol injection is chloramphenicol, which is a fat-soluble drug and an inhibitor. It enters the cell through diffusion and combines with the bacterial ribosome, thereby preventing protein synthesis and exerting antibacterial activity. Chloramphenicol is a broad-spectrum antimicrobial drug and has certain anti-blood activity against aerobic Gram-negative bacteria, Gram-positive bacteria, anaerobic bacteria, Rickettsia, spirochetes, and Chlamydia.
[0003] Chloramphenicol injections mostly use propylene glycol as the main solvent to dissolve chloramphenicol, but propylene glycol itself has low toxicity and hemolysis, and using propylene glycol as the main solvent to prepare injections is dangerous. In addition, due to the low water solubility of chloramphenicol and the easy occurrence of amide hydrolysis in chloramphenicol aqueous solutions, which leads to a decrease in the chloramphenicol content and even the production of toxic by-products, large amounts of pure water are rarely used to replace propylene glycol as the solvent for chloramphenicol injections at this stage. On this basis, in order to improve the safety of chloramphenicol injections, reduce the hydrolysis of effective substances in chloramphenicol injections, and rationally optimize the formulation and process of the injections, it is an important research direction at this stage. Summary of the invention
[0004] In view of the deficiencies in the prior art, the present invention provides a chloramphenicol injection and a preparation method thereof, which effectively improves the stability of the chloramphenicol injection, prevents the degradation of chloramphenicol, and reduces the amount of propylene glycol used, thereby improving the safety of the injection.
[0005] To achieve the above objectives, the technical solution of the present invention is implemented through the following technical solutions:
[0006] A chloramphenicol injection. The chloramphenicol injection, calculated as 1000 ml, has the following components: 125-250 g chloramphenicol, 400-500 ml propylene glycol, 100-200 ml castor oil for injection, 1-1.8 g surfactant, 1 g sodium dihydrogen phosphate, 0.1 g disodium hydrogen phosphate, 1 g sodium bisulfite, 0.1 g disodium ethylenediaminetetraacetic acid, and water for injection is added to make up to 1000 ml.
[0007] Preferably, the surfactant is a mixture of sodium oleate and sodium citrate in a mass ratio of 2:1.
[0008] The preparation method of the chloramphenicol injection comprises the following steps:
[0009] S1, preheat propylene glycol and add chloramphenicol, stir thoroughly to dissolve, then add a surfactant and homogenize to obtain a first mixed solution for standby use;
[0010] S2, adding castor oil for injection to the first mixed solution, centrifugally stirring and then homogenizing by pressure change to obtain a second mixed solution for standby use;
[0011] S3, mixing sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite and disodium ethylenediaminetetraacetate, and then adding water for injection according to a material-liquid mass ratio of 1:15-20, stirring and dissolving in a water bath, and obtaining a third mixed solution for standby use;
[0012] S4. Add the third mixed solution dropwise to the second mixed solution while stirring. After the addition is completed, filter the solution and add water for injection to make up the balance. Then, perform ultrasonic homogenization at 400-600W at 0-5°C for 10-20min, return the solution to room temperature, fill the solution with nitrogen, seal the solution and sterilize the solution to obtain chloramphenicol injection.
[0013] Preferably, in step S1, the temperature at which propylene glycol is preheated is 60-70° C., and the rotation speed for adding chloramphenicol and stirring and dissolving it fully is 600-800 r / min, and the stirring time is 20-40 min.
[0014] Preferably, the homogenization in step S1 is carried out by ultrasonic homogenization at 400-600W for 10-20min at a temperature of 40-50°C.
[0015] Preferably, the rotation speed of the centrifugal stirring in step S2 is 3200-4500 r / min, and the stirring time is 10-20 min.
[0016] Preferably, the variable pressure homogenization method in step S2 is to adjust the pressure to 0.2-0.4Mpa, 0.8-1.2Mpa, and 1.4-1.6Mpa in sequence and use 400-600W ultrasonic homogenization for 8-15min respectively.
[0017] Preferably, the temperature for stirring and dissolving in a water bath in step S3 is 60-70° C., the stirring speed is 200-400 r / min, and the stirring time is 20-30 min.
[0018] Preferably, in step S4, the dripping speed of the stirring while dripping is 2-3 drops / second, the stirring speed is 180-250r / min, and the filtering method is to filter using 5μm and 0.22μm filters in sequence.
[0019] Preferably, the sterilization method in step S4 is high temperature sterilization at 105° C. for 40 minutes.
[0020] The present invention provides a chloramphenicol injection and a preparation method thereof, which has the advantages of:
[0021] The present invention adopts propylene glycol with a relatively low content to prepare an injection, thereby improving the safety of the injection; and prepares a microemulsion by adding castor oil and a propylene glycol solution of chloramphenicol for centrifugal stirring and pressure-variable homogenization, and subsequently mixing and dispersing with other auxiliary agents and water for injection for homogenization, thereby improving the stability of chloramphenicol, preventing chloramphenicol from being degraded in an aqueous solution, and comprehensively improving the safety of the chloramphenicol injection. DETAILED DESCRIPTION
[0022] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention is clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0023] The sources of raw materials used in the following examples and comparative examples are as follows:
[0024] Chloramphenicol (for injection): Wuhan Wuyao Pharmaceutical Co., Ltd.;
[0025] Propylene glycol: Xi'an Xinfengda Pharmaceutical Excipients Co., Ltd.;
[0026] Castor oil for injection: Lipoid GmbH, Germany;
[0027] Sodium dihydrogen phosphate: Hebei Tiancheng Pharmaceutical Co., Ltd.;
[0028] Disodium hydrogen phosphate: Hebei Tiancheng Pharmaceutical Co., Ltd.;
[0029] Sodium bisulfite: Wuhan Wuyao Pharmaceutical Co., Ltd.;
[0030] Disodium ethylenediaminetetraacetate: Wuhan Wuyao Pharmaceutical Co., Ltd.;
[0031] The surfactant is a mixture of sodium oleate and sodium citrate in a mass ratio of 2:1.
[0032] Embodiment 1:
[0033] Production of 1000mL of chloramphenicol injection (Specification: 0.25g of chloramphenicol per 2mL of chloramphenicol injection)
[0034] (1) Preparation: 250 g of chloramphenicol, 500 mL of propylene glycol, 200 mL of castor oil for injection, 1.8 g of surfactant, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetate, and the balance is water for injection;
[0035] (2) Preheating propylene glycol to 65° C., adding chloramphenicol, stirring and dissolving at 600 r / min for 30 min, then adding a surfactant, and ultrasonically homogenizing at 45° C. for 15 min at 400 W to obtain a first mixed solution for later use;
[0036] (3) adding castor oil for injection to the first mixed solution, centrifugally stirring at a speed of 4000 r / min for 15 min, then adjusting the pressure to 0.3 MPa, 1 MPa, and 1.5 MPa in sequence, and homogenizing with an ultrasonic power of 600 W for 10 min at each pressure to obtain a second mixed solution for standby use;
[0037] (4) Sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite, and disodium ethylenediaminetetraacetate are mixed, and then water for injection is added at a material-liquid mass ratio of 1:15, and stirred at a speed of 300 r / min for 25 minutes at a water bath temperature of 65° C. to obtain a third mixed solution for use;
[0038] (5) The third mixed solution is added dropwise to the second mixed solution at a dropping speed of 2-3 drops / second, and stirred at a speed of 200 r / min. After the addition is completed, the mixture is filtered using a 5 μm filter and a 0.22 μm filter in turn. The filtrate is then added to water for injection to make up the balance, and then subjected to low-temperature 600 W ultrasonic homogenization at 2°C for 15 min. The mixture is returned to room temperature, nitrogen is filled and sealed, and then sterilized at 105°C for 40 min to obtain chloramphenicol injection.
[0039] Embodiment 2:
[0040] Produce 1000mL of chloramphenicol injection (specification: 0.125g of chloramphenicol in every 2mL of chloramphenicol injection);
[0041] (1) Preparation: 125 g of chloramphenicol, 400 mL of propylene glycol, 100 mL of castor oil for injection, 1 g of surfactant, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetate, and the balance is water for injection;
[0042] Steps (2) to (5) are the same as in Example 1.
[0043] Comparative Example 1:
[0044] Produce 1000mL of chloramphenicol injection (specification: 0.125g of chloramphenicol in every 2mL of chloramphenicol injection);
[0045] (1) Preparation: 125 g of chloramphenicol, 400 mL of propylene glycol, 100 mL of castor oil for injection, 1 g of surfactant, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetate, and the balance is water for injection;
[0046] (2) Preheating propylene glycol to 65° C., adding chloramphenicol, stirring and dissolving at 600 r / min for 30 min, then adding a surfactant, and ultrasonically homogenizing at 45° C. for 15 min at 400 W to obtain a first mixed solution for later use;
[0047] (3) adding castor oil for injection to the first mixed solution, centrifuging and stirring at a speed of 4000 r / min for 15 min to obtain a second mixed solution for later use;
[0048] (4) Sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite, and disodium ethylenediaminetetraacetate are mixed, and then water for injection is added at a material-liquid mass ratio of 1:15, and stirred at a speed of 300 r / min for 25 minutes at a water bath temperature of 65° C. to obtain a third mixed solution for use;
[0049] (5) The third mixed solution is added dropwise to the second mixed solution at a dropping speed of 2-3 drops / second, and stirred at a speed of 200 r / min. After the addition is completed, the mixture is filtered using a 5 μm filter and a 0.22 μm filter in turn. The filtrate is then added to water for injection to make up the balance, and then subjected to low-temperature 600 W ultrasonic homogenization at 2°C for 15 min. The mixture is returned to room temperature, nitrogen is filled and sealed, and then sterilized at 105°C for 40 min to obtain chloramphenicol injection.
[0050] Comparative Example 2:
[0051] Produce 1000mL of chloramphenicol injection (specification: 0.125g of chloramphenicol in every 2mL of chloramphenicol injection);
[0052] (1) Preparation: 125 g of chloramphenicol, 400 mL of propylene glycol, 100 mL of castor oil for injection, 1 g of surfactant, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetate, and the balance is water for injection;
[0053] (2) Preheating propylene glycol to 65° C., adding chloramphenicol, stirring and dissolving at 600 r / min for 30 min, then adding a surfactant, and ultrasonically homogenizing at 45° C. for 15 min at 400 W to obtain a first mixed solution for later use;
[0054] (3) adding castor oil for injection to the first mixed solution, centrifugally stirring at a speed of 4000 r / min for 15 min, then adjusting the pressure to 0.3 MPa, 1 MPa, and 1.5 MPa in sequence, and homogenizing with an ultrasonic power of 600 W for 10 min at each pressure to obtain a second mixed solution for standby use;
[0055] (4) Sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite, and disodium ethylenediaminetetraacetate are mixed, and then water for injection is added at a material-liquid mass ratio of 1:15, and stirred at a speed of 300 r / min for 25 minutes at a water bath temperature of 65° C. to obtain a third mixed solution for use;
[0056] (5) The third mixed solution was added to the second mixed solution, stirred at a speed of 200 r / min for 20 min, filtered using a 5 μm filter and a 0.22 μm filter in turn, and the filtrate was added with water for injection to make up the balance, and then ultrasonically homogenized at 600 W for 15 min, sealed with nitrogen, and sterilized at 105° C. for 40 min to obtain chloramphenicol injection.
[0057] Comparative Example 3:
[0058] Produce 1000mL of chloramphenicol injection (specification: 0.125g of chloramphenicol in every 2mL of chloramphenicol injection);
[0059] (1) Preparation: 125 g of chloramphenicol, 400 mL of propylene glycol, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetate, and the balance is water for injection;
[0060] (2) Preheating propylene glycol to 65° C., adding chloramphenicol, stirring and dissolving at 600 r / min for 30 min, and ultrasonically homogenizing at 45° C. for 15 min at 400 W to obtain a first mixed solution for later use;
[0061] (3) Sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite, and disodium ethylenediaminetetraacetate are mixed, and then water for injection is added at a material-liquid mass ratio of 1:15, and stirred at a speed of 300 r / min for 25 minutes at a water bath temperature of 65° C. to obtain a second mixed solution for use;
[0062] (4) The second mixed solution was added to the first mixed solution, stirred at a speed of 200 r / min for 20 min, filtered using a 5 μm filter and a 0.22 μm filter in turn, and the filtrate was added with water for injection to make up the balance, and then ultrasonically homogenized at 600 W for 15 min, sealed with nitrogen, and sterilized at 105° C. for 40 min to obtain chloramphenicol injection.
[0063] Detection:
[0064] The chloramphenicol content (based on the specification content as 100%) of the chloramphenicol injection prepared in the above Examples 1-2 and Comparative Examples 1-3 was detected respectively, as well as the stability when stored in different environments:
[0065] 1. Stability at room temperature:
[0066] Each group of chloramphenicol injection was filled into 2 mL ampoule bottles and placed under 25°C ± 2°C and relative humidity of 60% ± 10%. The chloramphenicol content after 0 day, 1 month, 3 months and 9 months was tested. The specific results are shown in the following figure 1:
[0067] Table 1
[0068]
[0069] 2. High temperature stability:
[0070] Each group of chloramphenicol injection was filled into 2 mL ampoule bottles, sterilized and placed in a stabilization box. The storage temperature was controlled at 60°C. The chloramphenicol content of each group of chloramphenicol injection was tested after 0, 10, 20 and 45 days of storage. The specific results are shown in Table 2 below:
[0071] Table 2
[0072]
[0073]
[0074] 3. Freeze-thaw stability:
[0075] After sterilization, each group of chloramphenicol injection was filled into 2 mL ampoule bottles, frozen at -18°C for 6 hours, and then thawed at room temperature for 4 hours. The freeze-thaw experiment was repeated for many times, and the chloramphenicol content of each group of chloramphenicol injection at 0, 1, 3, 6 and 10 times of freeze-thaw was recorded. The specific results are shown in Table 3 below:
[0076] Table 3
[0077]
[0078] From the above test, it can be seen that the chloramphenicol injection obtained in Example 1 and Example 2 has higher stability, and the propylene glycol used is also less than that in Comparative Example 3.
[0079] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A chloramphenicol injection, characterized in that: The chloramphenicol injection is calculated based on 1000 ml, and the contents of each component are as follows: 125-250 g of chloramphenicol, 400-500 ml of propylene glycol, 100-200 ml of castor oil for injection, 1-1.8 g of surfactant, 1 g of sodium dihydrogen phosphate, 0.1 g of disodium hydrogen phosphate, 1 g of sodium bisulfite, 0.1 g of disodium ethylenediaminetetraacetic acid, and water for injection is added to 1000 ml.
2. Chloramphenicol injection according to claim 1, characterized in that: The surfactant is a mixture of sodium oleate and sodium citrate in a mass ratio of 2:
1.
3. A method for preparing chloramphenicol injection as claimed in any one of claims 1 to 2, characterized in that: The preparation method comprises the following steps: S1, preheat propylene glycol and add chloramphenicol, stir thoroughly to dissolve, then add a surfactant and homogenize to obtain a first mixed solution for standby use; S2, adding castor oil for injection to the first mixed solution, centrifugally stirring and then homogenizing by pressure change to obtain a second mixed solution for standby use; S3, mixing sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium bisulfite and disodium ethylenediaminetetraacetate, and then adding water for injection according to a material-liquid mass ratio of 1:15-20, stirring and dissolving in a water bath, and obtaining a third mixed solution for standby use; S4. Add the third mixed solution dropwise to the second mixed solution while stirring. After the addition is completed, filter the solution and add water for injection to make up the balance. Then, perform ultrasonic homogenization at 400-600W at 0-5°C for 10-20min, return the solution to room temperature, fill the solution with nitrogen, seal the solution and sterilize the solution to obtain chloramphenicol injection.
4. The preparation method according to claim 3, characterized in that: In the step S1, the temperature at which the propylene glycol is preheated is 60-70° C., and the rotation speed for adding chloramphenicol and stirring and dissolving it fully is 600-800 r / min, and the stirring time is 20-40 min.
5. The preparation method according to claim 3, characterized in that: The homogenization method in step S1 is to use 400-600W ultrasonic homogenization at a temperature of 40-50°C for 10-20 minutes.
6. The preparation method according to claim 3, characterized in that: The rotation speed of the centrifugal stirring in step S2 is 3200-4500 r / min, and the stirring time is 10-20 min.
7. The preparation method according to claim 3, characterized in that: The variable pressure homogenization method in step S2 is to adjust the pressure to 0.2-0.4Mpa, 0.8-1.2Mpa, and 1.4-1.6Mpa in sequence and use 400-600W ultrasonic homogenization for 8-15min respectively.
8. The preparation method according to claim 3, characterized in that: In step S3, the temperature of the water bath stirring dissolution is 60-70° C., the stirring speed is 200-400 r / min, and the stirring time is 20-30 min.
9. The preparation method according to claim 3, characterized in that: The dripping speed of the stirring while dripping in step S4 is 2-3 drops / second, the stirring speed is 180-250r / min, and the filtering method is to use 5μm and 0.22μm filters in sequence for filtering.
10. The preparation method according to claim 3, characterized in that: The sterilization method in step S4 is high temperature sterilization at 105° C. for 40 minutes.
